FACTORS AFFECTING INTERMEDIATE-DOSE METHOTREXATE (MTX) CLEARANCE (CL) IN THE TREATMENT OF ACUTE LYMPHOCYTIC-LEUKEMIA (ALL)

被引：0
|
作者：
CROM, WR [1 ]
GLYNN, AM [1 ]
EVANS, WE [1 ]
机构：
[1] ST JUDE CHILDRENS RES HOSP,DIV PHARMACEUT,PHARMACOKINET & PHARMACODYNAM SECT,MEMPHIS,TN 38101
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1985年 / 37卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：188 / 188
页数：1
相关论文
共 50 条
  • [1] DISPOSITION OF INTERMEDIATE-DOSE METHOTREXATE IN CHILDREN WITH ACUTE LYMPHOCYTIC-LEUKEMIA
    EVANS, WE
    STEWART, CF
    HUTSON, PR
    CAIRNES, DA
    BOWMAN, WP
    YEE, GC
    CROM, WR
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1982, 16 (11): : 839 - 842
  • [2] COMPARISON OF INTERMEDIATE-DOSE METHOTREXATE WITH CRANIAL IRRADIATION FOR THE POST-INDUCTION TREATMENT OF ACUTE LYMPHOCYTIC-LEUKEMIA IN CHILDREN
    FREEMAN, AI
    WEINBERG, V
    BRECHER, ML
    JONES, B
    GLICKSMAN, AS
    SINKS, LF
    WEIL, M
    PLEUSS, H
    HANANIAN, J
    BURGERT, EO
    GILCHRIST, GS
    NECHELES, T
    HARRIS, M
    KUNG, F
    PATTERSON, RB
    MAURER, H
    LEVENTHAL, B
    CHEVALIER, L
    FORMAN, E
    HOLLAND, JF
    NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (09): : 477 - 484
  • [3] PHARMACOKINETIC EVALUATION OF HIGH-DOSE ORAL METHOTREXATE (MTX) IN CHILDREN WITH ACUTE LYMPHOCYTIC-LEUKEMIA (ALL)
    EVANS, W
    RIVERA, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 266 - 266
  • [4] HIGH DOSE METHOTREXATE (HDM) IN ACUTE LYMPHOCYTIC-LEUKEMIA (ALL)
    FREEMAN, AI
    WANG, JJ
    SINKS, LF
    PEDIATRIC RESEARCH, 1977, 11 (01) : 55 - 55
  • [5] HIGH DOSE METHOTREXATE (HDM) IN ACUTE LYMPHOCYTIC-LEUKEMIA (ALL)
    FREEMAN, AI
    SINKS, LF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 278 - 278
  • [6] THE TREATMENT OF CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA WITH PROPHYLACTIC INTRATHECAL AND SYSTEMIC INTERMEDIATE-DOSE (150 MG/M2) METHOTREXATE
    MUCHI, H
    IJIMA, H
    SUDA, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1982, 12 (03) : 363 - 370
  • [7] TREATMENT OF ACUTE LYMPHOCYTIC LEUKEMIA (ALL) WITH INTERMITTENT HIGH DOSE METHOTREXATE (MTX) AND ASPARAGINASE (A'ASE)
    CAPIZZI, R
    CASTRO, O
    ASPNES, G
    BOBROW, S
    BERTINO, J
    FINCH, S
    PEARSON, H
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 182 - 182
  • [8] INTERMEDIATE-DOSE METHOTREXATE IN THE TREATMENT OF CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA - LACK OF BENEFIT DURING MAINTENANCE THERAPY FOLLOWING INTENSIVE INDUCTION THERAPY
    JANKASCHAUB, GE
    WINKLER, K
    JURGENS, H
    GOEBEL, U
    GUTJAHR, P
    SPAAR, HJ
    EUROPEAN JOURNAL OF PEDIATRICS, 1986, 145 (1-2) : 14 - 17
  • [9] COMPARISON OF INTERMEDIATE DOSE METHOTREXATE (IDM) WITH CRANIAL RADIATION (CRT) IN CHILDREN WITH ACUTE LYMPHOCYTIC-LEUKEMIA (ALL)
    FREEMAN, AI
    WEINBERG, VE
    BRECHER, ML
    JONES, B
    GLICKSMAN, AS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 486 - 486
  • [10] STANDARD TREATMENT OF AVERAGE RISK ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) WITH OR WITHOUT PERIODIC INFUSIONS OF MODERATE DOSE METHOTREXATE (MTX) - RESULTS OF A RANDOMIZED TRIAL
    MEADOWS, AT
    LANGE, B
    BLATT, J
    SATHER, H
    HAMMOND, D
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (06): : 387 - 387
12345